Show newer

Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece medrxiv.org/content/10.1101/20

A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19 medrxiv.org/content/10.1101/20

Osteonecrosis in Gaucher Disease in the era of multiple therapies: biomarker set for risk stratification from a tertiary referral center medrxiv.org/content/10.1101/20

Epigenetic clock acceleration is linked to earlier onset and phenoconversion age in REM sleep behavior disorder medrxiv.org/content/10.1101/20

Functional Magnetic Resonance Imaging of the amygdala and subregions at 3 Tesla: A scoping review medrxiv.org/content/10.1101/20

What are the priority needs for those caring for children and young people with complex neurodisability within an ethnically diverse UK context? - The feasibility phase of the ENCOMPASS study medrxiv.org/content/10.1101/20

Effect of an enhanced public health contact tracing intervention on the secondary transmission of SARS-CoV-2 in educational settings: the four-way decomposition analysis medrxiv.org/content/10.1101/20

Urgent Transcatheter Edge-to-Edge Repair for Severe Mitral Regurgitation with Flail Leaflet in Critically Ill Patients medrxiv.org/content/10.1101/20

Facility-based and virtual cardiac rehabilitation in young patients with heart disease during the COVID-19 era medrxiv.org/content/10.1101/20

Development and validation of a novel in-vivo vascular injury score for prediction of in-stent restenosis medrxiv.org/content/10.1101/20

Sequential viral introductions and spread of BA.1 drove the Omicron wave across Pakistani provinces medrxiv.org/content/10.1101/20

Gene therapy using optimized LentiHBBT87Q vector in two patients with transfusion dependent β-thalassemia medrxiv.org/content/10.1101/20

A gene pathogenicity tool 'GenePy' identifies missed biallelic diagnoses in the 100,000 Genomes Project medrxiv.org/content/10.1101/20

Mapping pQTLs of circulating inflammatory proteins identifies drivers of and novel therapeutic targets medrxiv.org/content/10.1101/20

CESCProg: A COMPACT PROGNOSTIC MODEL AND NOMOGRAM FOR CERVICAL CANCER BASED ON miRNA BIOMARKERS medrxiv.org/content/10.1101/20

The amino acid stress sensing eIF2α kinase GCN2 is a survival biomarker for malignant mesothelioma medrxiv.org/content/10.1101/20

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia medrxiv.org/content/10.1101/20

Show older
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.